Netarsudil as an Adjunctive Therapy: Efficacy and Factors Contributing to a Favorable IOP-Lowering Effect.

Authors:
Samuel S; El Helwe H; Neeson CE; Hall N; Meshkin RS and 4 more

Journal:
J Ophthalmol

Publication Year: 2022

DOI:
10.1155/2022/6925027

PMCID:
PMC9822751

PMID:
36620524

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Ophthalmol

Abbreviation: J Ophthalmol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ophthalmology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Accommodation and Binocular Vision in Children with Myopic Anisometropia.
Zhuang CC; Zhang L; Pan SS and 2 more (2024) - Transparency Score: 2/6
Advanced Periocular Basal Cell Carcinoma with Orbital Invasion: Update on Management and Treatment …
Bengoa-González A; Mencía-Gutiérrez E; Garrido M and 2 more (2024) - Transparency Score: 2/6
Clinical and Imaging Characteristics of Metastatic Orbital Tumours in North China.
Zhao Y; Yu S; Mu M and 3 more (2024) - Transparency Score: 3/6
Corneal Epithelial Thickness Mapping: A Major Review.
Abtahi MA; Beheshtnejad AH; Latifi G and 9 more (2024) - Transparency Score: 2/6
Long-Term Surgical Outcomes of Glaucoma Drainage Implants in Eyes with Preoperative Intraocular Pre…
Hallaj S; Wong JC; Hock LE and 7 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors were employed at the Glaucoma department at Mass. Eye and Ear. The authors declare that they have no conflicts of interest."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025